Genitourinary cancers affect the male reproductive organs, as well as the urinary systems in both men and women. Our patients’ comfort and quality of life is at the forefront when we treat cancers involving the prostate, bladder, kidney, and testes.
- Prostate cancer is the second-leading cause of cancer death in men, after lung cancer. One in every six men will develop prostate cancer during his lifetime.
- Men are four times more likely to have bladder cancer than women. It’s the fourth most frequently diagnosed cancer in men.
- Renal (kidney) cancer is among the 10 most common cancers in both men and women. The lifetime risk for developing kidney cancer is about 1 in 75, and the risk is higher in men than in women.
- Testicular cancer is rare, but remains the most frequent cancer in males under age 35. It is highly treatable, with a 99-percent survival rate, if the cancer has not spread.
Weekly pathology review and tumor conferences are a hallmark of our program, giving you the benefit of a team-based approach to your care.
In addition, Texas Oncology's continued participation in major clinical trials has shaped the way genitourinary cancers are managed. The practice has been recognized over the past 10 years for participation in trials that resulted in FDA approval of several drugs for renal cell (kidney) cancer and prostate cancer. The research goal is simple: to find the cure for these cancers. We take pride in bringing the best research options to you.
We work closely with your primary care physicians to provide you with the best care possible from diagnosis through survivorship.
Find a genitourinary oncologist close to you.